Bill Colston
CIK 1783315 · View on SEC EDGAR ↗
First SEC filing: June 17, 2022 · Latest: June 17, 2022
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 15, 2022 | LAB | A | 42,571 | — | — | 42,571 Direct | — | Acquired | (price as of 2026-08-20) |
| June 15, 2022 | LAB | A | 30,914 | — | — | 59,288 Direct | +108.95% | Acquired | (price as of 2026-08-20) |
| May 25, 2021 | LAB | A | 15,402 | — | — | 15,402 Direct | — | Acquired | (price as of 2026-08-20) |
| May 25, 2021 | LAB | A | 10,342 | — | — | 28,374 Direct | +57.35% | Acquired | (price as of 2026-08-20) |
| June 23, 2020 | LAB | A | 20,993 | — | — | 20,993 Direct | — | Acquired | (price as of 2026-08-20) |
| June 23, 2020 | LAB | A | 13,369 | — | — | 18,032 Direct | +286.70% | Acquired | (price as of 2026-08-20) |
| July 23, 2019 | LAB | A | 8,724 | — | — | 8,724 Direct | — | Acquired | (price as of 2026-08-20) |
| July 23, 2019 | LAB | A | 7,476 | — | — | 7,476 Direct | — | Acquired | (price as of 2026-08-20) |
| July 23, 2019 | LAB | A | 4,663 | — | — | 4,663 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 15, 2022 | LAB | Stock Option (Right to Buy) | Common Stock (42,571) | $1.86 | June 15, 2032 | 42,571 | Acquired |
| May 25, 2021 | LAB | Stock Option (Right to Buy) | Common Stock (15,402) | $5.56 | May 25, 2031 | 15,402 | Acquired |
| June 23, 2020 | LAB | Stock Option (Right to Buy) | Common Stock (20,993) | $3.74 | June 23, 2030 | 20,993 | Acquired |
| July 23, 2019 | LAB | Stock Option (Right to Buy) | Common Stock (8,724) | $11.54 | July 23, 2029 | 8,724 | Acquired |
| July 23, 2019 | LAB | Stock Option (Right to Buy) | Common Stock (7,476) | $11.54 | July 23, 2029 | 7,476 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).